|
|
||||||||||
|
J Am Coll Cardiol, 2004; 44:855-858, doi:10.1016/j.jacc.2004.05.053 © 2004 by the American College of Cardiology Foundation |

* Cardiovascular Institute
Department of Biostatistics, University of Pittsburgh, Pittsburgh, PennsylvaniaUSA
Manuscript received March 15, 2004; revised manuscript received April 23, 2004, accepted May 3, 2004.
* Reprint requests and correspondence: Dr. Samir Saba, Division of Cardiac Electrophysiology, University of Pittsburgh Medical Center, 200 Lothrop Street, B535 PUH, Pittsburgh, Pennsylvania 15213 (Email: sabas{at}msx.upmc.edu).
OBJECTIVES: We analyzed the incidence of implantable cardioverter-defibrillator (ICD) therapy in survivors of cardiac arrest (CA) in the U.S. from 1996 through 2001.
BACKGROUND: Cardiac arrest is a class I indication for ICD therapy. The current patterns of ICD utilization in survivors of CA have not been fully examined.
METHODS: We searched a representative sample of all hospital discharges for patients admitted with the primary diagnosis of CA who survived to hospital discharge. Patients with a concomitant diagnosis of acute myocardial infarction or previous ICD in situ were excluded.
RESULTS: From 1996 to 2001, 113,262 patients were admitted for CA. Of those, 63,745 (56.3%) did not survive to hospital discharge. Of the remaining 49,517 patients, 30.7% received an ICD before discharge, with a gradual increase in implantation rates from 1996 (23.6%) to 2001 (46.3%). Using logistic regression for the years 2000 and 2001, patients who were discharged without an ICD were older (odds ratio [OR] 0.93 for every 10-year increase in age, p < 0.001), more likely to be African American (OR 0.19, p < 0.001), and more likely to be admitted to a smaller hospital (OR 2.24 for each additional 100 beds, p < 0.001). These predictors were independent of other co-morbid illnesses.
CONCLUSIONS: Although they are increasing, the rates of ICD therapy after CA remain very low. There are gross discrepancies by race. At a time when newer indications for ICD implantation are emerging, efforts should be focused on identifying the causes of this underutilization and discrepancies in survivors of CA.
| |||||||||
This article has been cited by other articles:
![]() |
L. H. Curtis, S. M. Al-Khatib, A. M. Shea, B. G. Hammill, A. F. Hernandez, and K. A. Schulman Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death JAMA, October 3, 2007; 298(13): 1517 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Birnie MB ChB MD, C. Sambell BSc, H. Johansen PhD, K. Williams MS, R. Lemery MD, M. S. Green MD, M. H. Gollob MD, D. S. Lee MD PhD, and A. S.L. Tang MD Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest Can. Med. Assoc. J., July 3, 2007; 177(1): 41 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Schoenfeld Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist Circulation, February 6, 2007; 115(5): 638 - 653. [Full Text] [PDF] |
||||
![]() |
L. Goldman Cost-Effectiveness in a Flat World -- Can ICDs Help the United States Get Rhythm? N. Engl. J. Med., October 6, 2005; 353(14): 1513 - 1515. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz The Year in Epidemiology, Health Services, and Outcomes Research J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1362 - 1370. [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al. Highlights of the year in JACC 2004 J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |